Ross Kedl, PhD

Professor of Immunology & Microbiology
University of Colorado

Ross KedlDr. Kedl received his PhD in 1997 in the Department of Laboratory Medicine and Pathology at the University of Minnesota in Minneapolis. Before joining the Faculty at the University of Colorado, Dr. Kedl was at 3M Pharmaceuticals working in their small molecule immune response modifier program. In his three years there, he spearheaded efforts at developing novel vaccine adjuvants, resulting in numerous publications and patents in the area of vaccine technology. Dr. Kedl returned to the academic sector in 2004 by joining the faculty in the Integrated Department of Immunology at the University of Colorado Health Sciences Center and National Jewish Medical Research Center where he continues to pursue the discovery and development of novel and clinically applicable vaccine technology. He is also the founder of a start-up pharmaceutical company, ImmuRx Inc., which focuses on developing therapeutic vaccines against chronic infectious diseases, such as HIV and cancer.

Biography from University of Colorado.

IDIGH Calendar

<<  <  October 2019  >  >>
 Mo  Tu  We  Th  Fr  Sa  Su 
   1  3  5  6
  7  810111213
141517181920
212224252627
282931   

Latest IDIGH Publications

  1. Lefebvre, T., Petitclerc, L., Hébert, M., Bilodeau, L., Sebastiani, G., Olivié, D., Gao, Z.-H., Sylvestre, M.-P., Cloutier, G., Nguyen, B. N., Gilbert, G. & Tang, A.
    (2019)
    .
    MRI cine-tagging of cardiac-induced motion for noninvasive staging of liver fibrosis
    .
    Journal of magnetic resonance imaging : JMRI
  2. Althoff, K. N., Chandran, A., Zhang, J., Arevalo, W. M., Gange, S. J., Sterling, T. R., Gill, M. J., Justice, A. C., Palella, F. J., Rebeiro, P. F., Silverberg, M. J., Mayor, A. M., Horberg, M. A., Thorne, J. E., Rabkin, C. S., Mathews, W. C., Klein, M. B., Humes, E., Lee, J., Hogg, R., Moore, R. D. & North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA.
    (2019)
    .
    LIFE EXPECTANCY DISPARITIES AMONG ADULTS WITH HIV IN THE UNITED STATES AND CANADA: THE IMPACT OF A REDUCTION IN DRUG- AND ALCOHOL-RELATED DEATHS USING THE LIVES SAVED SIMULATION (LISSO) MODEL
    .
    American journal of epidemiology
  3. Horwitz, D. A., Fahmy, T. M., Piccirillo, C. A. & La Cava, A.
    (2019)
    .
    Rebalancing Immune Homeostasis to Treat Autoimmune Diseases
    .
    Trends in immunology
  4. Massanella, M., Bakeman, W., Sithinamsuwan, P., Fletcher, J. L. K., Chomchey, N., Tipsuk, S., Chalermchai, T., Routy, J.-P., Ananworanich, J., Valcour, V. G., Chomont, N. & SEARCH 011 Study Group.
    (2019)
    .
    Infrequent HIV infection of circulating monocytes during antiretroviral therapy
    .
    Journal of virology
  5. Zhang, H., Carnevale, G., Polese, B., Simard, M., Thurairajah, B., Khan, N., Gentile, M. E., Fontes, G., Vinh, D. C., Pouliot, R. & King, I. L.
    (2019)
    .
    CD109 Restrains Activation of Cutaneous IL-17-Producing γδ T Cells by Commensal Microbiota
    .
    Cell reports
    ,
    vol
    .
    29
    ,
    p
    .
    391-405.e5
    .
More publications